Placebo + Metformin for medulloblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Jan 2014: Trial registered, NCT02040376
  2. 13 Jun 2014: Trial started, NCT02040376

The trials

NCT02040376: Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma

State
Completed
Phase
Phase 3
People
24 taking part
Started
13 Jun 2014
Primary completion
15 Dec 2017
Arms
Group A (Crossover Group 1), Group B (Crossover Group 2)
Results
None posted
  1. 20 Jan 2014: Trial registered
  2. 13 Jun 2014: Trial started
  3. 15 Dec 2017: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.